OptimizeRx Corporation (OPRX) Earnings Call Analysis
NASDAQ · Healthcare · Health Information Services
Earnings Reports
-
OptimizeRx (OPRX) Q1 2026: DAP Subscription Revenue Jumps 45% as Platform Model Accelerates
May 13, 2026
-
OptimizeRx (OPRX) Q4 2025: Gross Margin Jumps 680bps as Specialty Mix Lifts Profitability
March 06, 2026
-
OptimizeRx (OPRX) Q3 2025: Gross Margin Climbs to 67%, Smoothing Revenue Model Sharpens 2026 Visibility
November 07, 2025
-
OptimizeRx (OPRX) Q2 2025: Contracted Revenue Up 30%, Expanding Mid-Market Pharma Penetration
August 08, 2025